Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions.
Saved in:
| Title: | Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions. |
|---|---|
| Authors: | Zhou Y; Clinical Immunology, Amgen Inc., South San Francisco, CA, USA., Zhang F; Global Biostatistical Sciences, Amgen, Inc. Thousand Oaks, CA, USA., Starcevic Manning M; Translational Safety and Bioanalytical Sciences, Amgen, Inc. Thousand Oaks, CA, USA., Hu Z; Translational Safety and Bioanalytical Sciences, Amgen, Inc. Thousand Oaks, CA, USA., Hsu CP; Clinical Pharmacology, Amgen, Inc. Thousand Oaks, CA, USA., Chen PW; Clinical Pharmacology, Amgen, Inc. Thousand Oaks, CA, USA., Peng C; Global Biostatistical Sciences, Amgen, Inc. Thousand Oaks, CA, USA., Loop B; Global Safety, Amgen Inc., Thousand Oaks, CA, USA., Mytych DT; Clinical Immunology, Amgen, Inc. Thousand Oaks, CA, USA., Paiva da Silva Lima G; Global Development, Neuroscience, Amgen, Inc. Thousand Oaks, CA, USA. |
| Source: | Cephalalgia : an international journal of headache [Cephalalgia] 2022 Jul; Vol. 42 (8), pp. 749-760. Date of Electronic Publication: 2022 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
